XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 30, 2023   6,934,265    
Beginning balance at Dec. 30, 2023 $ 212,101 $ 0 $ 224,283 $ (12,182)
Increase (Decrease) in Shareholders' Equity        
Net income 13,691   13,691  
Foreign currency translation adjustment (1,105)     (1,105)
Share-based compensation expense 1,039 $ 1,039    
Restricted shares vesting (in shares)   33,441    
Redemption of vested employee restricted shares for tax withholding (in shares)   (12,526)    
Redemption of vested employee restricted shares for tax withholding (1,631) $ (1,631)    
Shares repurchased (in shares)   (65,882)    
Shares repurchased (9,242) $ 592 (9,834)  
Accrued excise tax on shares repurchased (65)   (65)  
Accrued dividends on unvested shares 77   77  
Cash dividends paid (per share) (3,075)   (3,075)  
Ending balance (in shares) at Mar. 30, 2024   6,889,298    
Ending balance at Mar. 30, 2024 211,790 $ 0 225,077 (13,287)
Beginning balance (in shares) at Dec. 30, 2023   6,934,265    
Beginning balance at Dec. 30, 2023 212,101 $ 0 224,283 (12,182)
Increase (Decrease) in Shareholders' Equity        
Net income 31,666      
Foreign currency translation adjustment 1,475      
Ending balance (in shares) at Sep. 28, 2024   6,761,582    
Ending balance at Sep. 28, 2024 204,513 $ 1,311 213,909 (10,707)
Beginning balance (in shares) at Mar. 30, 2024   6,889,298    
Beginning balance at Mar. 30, 2024 211,790 $ 0 225,077 (13,287)
Increase (Decrease) in Shareholders' Equity        
Net income 6,538   6,538  
Foreign currency translation adjustment (315)     (315)
Share-based compensation expense 1,357 $ 1,357    
Restricted shares vesting (in shares)   6,143    
Redemption of vested employee restricted shares for tax withholding (in shares)   (2,340)    
Redemption of vested employee restricted shares for tax withholding (346) $ (346)    
Shares repurchased (in shares)   (140,497)    
Shares repurchased (24,106) $ (1,011) (23,095)  
Accrued excise tax on shares repurchased (235)   (235)  
Accrued dividends on unvested shares (33)   (33)  
Cash dividends paid (per share) (2,901)   (2,901)  
Ending balance (in shares) at Jun. 29, 2024   6,752,604    
Ending balance at Jun. 29, 2024 191,749 $ 0 205,351 (13,602)
Increase (Decrease) in Shareholders' Equity        
Net income 11,437   11,437  
Foreign currency translation adjustment 2,895     2,895
Share-based compensation expense 1,364 $ 1,364    
Restricted shares vesting (in shares)   9,272    
Redemption of vested employee restricted shares for tax withholding (in shares)   (294)    
Redemption of vested employee restricted shares for tax withholding (53) $ (53)    
Accrued excise tax on shares repurchased 16   16  
Accrued dividends on unvested shares (21)   (21)  
Cash dividends paid (per share) (2,874)   (2,874)  
Ending balance (in shares) at Sep. 28, 2024   6,761,582    
Ending balance at Sep. 28, 2024 $ 204,513 $ 1,311 213,909 (10,707)
Beginning balance (in shares) at Dec. 28, 2024 6,768,575 6,768,575    
Beginning balance at Dec. 28, 2024 $ 212,073 $ 1,663 225,461 (15,051)
Increase (Decrease) in Shareholders' Equity        
Net income 18,002   18,002  
Foreign currency translation adjustment 1,743     1,743
Share-based compensation expense 1,390 $ 1,390    
Restricted shares vesting (in shares)   34,780    
Redemption of vested employee restricted shares for tax withholding (in shares)   (13,462)    
Redemption of vested employee restricted shares for tax withholding (2,454) $ (2,454)    
Accrued excise tax on shares repurchased 39   39  
Accrued dividends on unvested shares 14   14  
Cash dividends paid (per share) (3,488)   (3,488)  
Ending balance (in shares) at Mar. 29, 2025   6,789,893    
Ending balance at Mar. 29, 2025 $ 227,319 $ 599 240,028 (13,308)
Beginning balance (in shares) at Dec. 28, 2024 6,768,575 6,768,575    
Beginning balance at Dec. 28, 2024 $ 212,073 $ 1,663 225,461 (15,051)
Increase (Decrease) in Shareholders' Equity        
Net income 41,597      
Foreign currency translation adjustment $ 4,505      
Ending balance (in shares) at Sep. 27, 2025 6,547,188 6,547,188    
Ending balance at Sep. 27, 2025 $ 201,655 $ 541 211,660 (10,546)
Beginning balance (in shares) at Mar. 29, 2025   6,789,893    
Beginning balance at Mar. 29, 2025 227,319 $ 599 240,028 (13,308)
Increase (Decrease) in Shareholders' Equity        
Net income 12,122   12,122  
Foreign currency translation adjustment 3,823     3,823
Share-based compensation expense 962 $ 962    
Restricted shares vesting (in shares)   4,487    
Redemption of vested employee restricted shares for tax withholding (in shares)   (2,144)    
Redemption of vested employee restricted shares for tax withholding (355) $ (355)    
Shares repurchased (in shares)   (230,673)    
Shares repurchased (43,150) $ (1,206) (41,944)  
Accrued excise tax on shares repurchased (428)   (428)  
Accrued dividends on unvested shares 77   77  
Cash dividends paid (per share) (3,370)   (3,370)  
Ending balance (in shares) at Jun. 28, 2025   6,561,563    
Ending balance at Jun. 28, 2025 197,000 $ 0 206,485 (9,485)
Increase (Decrease) in Shareholders' Equity        
Net income 11,473   11,473  
Foreign currency translation adjustment (1,061)     (1,061)
Share-based compensation expense 1,579 $ 1,579    
Restricted shares vesting (in shares)   7,456    
Redemption of vested employee restricted shares for tax withholding (in shares)   (299)    
Redemption of vested employee restricted shares for tax withholding (53) $ (53)    
Shares repurchased (in shares)   (21,532)    
Shares repurchased (3,999) $ (985) (3,014)  
Accrued excise tax on shares repurchased (27)   (27)  
Accrued dividends on unvested shares (17)   (17)  
Cash dividends paid (per share) $ (3,240)   (3,240)  
Ending balance (in shares) at Sep. 27, 2025 6,547,188 6,547,188    
Ending balance at Sep. 27, 2025 $ 201,655 $ 541 $ 211,660 $ (10,546)